# Dianthus Therapeutics, Inc. /DE/ (DNTH) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Dianthus Therapeutics, Inc. /DE/'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/DNTH/mda/fy2025/): filed 2026-03-09; accession 0001690585-26-000006 (https://www.sec.gov/Archives/edgar/data/1690585/000169058526000006/dnth-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/DNTH/mda/fy2024/): filed 2025-03-11; accession 0000950170-25-037131 (https://www.sec.gov/Archives/edgar/data/1690585/000095017025037131/dnth-20241231.htm)
- [FY 2023 MD&A](/company/DNTH/mda/fy2023/): filed 2024-03-21; accession 0000950170-24-034681 (https://www.sec.gov/Archives/edgar/data/1690585/000095017024034681/dnth-20231231.htm)
- [FY 2022 MD&A](/company/DNTH/mda/fy2022/): filed 2023-03-23; accession 0000950170-23-009331 (https://www.sec.gov/Archives/edgar/data/1690585/000095017023009331/mgta-20221231.htm)
- [FY 2021 MD&A](/company/DNTH/mda/fy2021/): filed 2022-03-08; accession 0001193125-22-068759 (https://www.sec.gov/Archives/edgar/data/1690585/000119312522068759/d237577d10k.htm)

Back to /company/DNTH/